Potential fungicidal effect of voriconazole against Candida spp
- PMID: 15737524
- DOI: 10.1016/j.ijantimicag.2004.11.007
Potential fungicidal effect of voriconazole against Candida spp
Abstract
In vitro fungistatic and fungicidal activities of voriconazole were evaluated against 114 isolates of Candida spp. MICs were determined using the NCCLS M27-A2 broth microdilution method. Minimum fungicidal concentrations (MFCs) were defined as the lowest drug concentrations that yielded < or = 5 colonies (> or = 98% killing activity). The fungicidal activity could be only evaluated against 45.6% of the isolates (52 of 114 isolates) because trailing growth occurred, and 30 of these 52 isolates (57.69%) showed MFC values < or = 1 mg/l. There was little or no fungicidal activity against C. albicans and C. tropicalis. In contrast, all C. krusei were killed by 1-2 mg/l voriconazole. In conclusion, our data show that the fungicidal effect of voriconazole against Candida spp. is species dependent.
Similar articles
-
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.J Clin Microbiol. 2001 Mar;39(3):954-8. doi: 10.1128/JCM.39.3.954-958.2001. J Clin Microbiol. 2001. PMID: 11230410 Free PMC article.
-
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.J Antimicrob Chemother. 2004 Feb;53(2):283-9. doi: 10.1093/jac/dkh053. Epub 2003 Dec 19. J Antimicrob Chemother. 2004. PMID: 14688039
-
In vitro activity of voriconazole against Candida species isolated in Taiwan.Int J Antimicrob Agents. 2004 Sep;24(3):294-6. doi: 10.1016/j.ijantimicag.2004.01.014. Int J Antimicrob Agents. 2004. PMID: 15325436
-
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria.Diagn Microbiol Infect Dis. 2011 Jul;70(3):330-43. doi: 10.1016/j.diagmicrobio.2011.03.002. Epub 2011 May 4. Diagn Microbiol Infect Dis. 2011. PMID: 21546199 Review.
-
Antifungal activity of the new azole UK-109, 496 (voriconazole).Mycoses. 1999;42 Suppl 2:83-6. Mycoses. 1999. PMID: 10865910 Review.
Cited by
-
Comparison of the antifungal effect of voriconazole and fluconazole on oral candidiasis before and during radiotherapy.Dent Res J (Isfahan). 2022 Nov 17;19:99. eCollection 2022. Dent Res J (Isfahan). 2022. PMID: 36605149 Free PMC article.
-
Molecular identification and in-vitro antifungal susceptibility testing of Candida species isolated from patients with onychomycosis.Curr Med Mycol. 2015 Dec;1(4):26-32. doi: 10.18869/acadpub.cmm.1.4.26. Curr Med Mycol. 2015. PMID: 28681001 Free PMC article.
-
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.Front Microbiol. 2017 Jan 12;7:2173. doi: 10.3389/fmicb.2016.02173. eCollection 2016. Front Microbiol. 2017. PMID: 28127295 Free PMC article. Review.
-
Efficacy of triazoles in a murine disseminated infection by Candida krusei.Antimicrob Agents Chemother. 2009 Aug;53(8):3585-8. doi: 10.1128/AAC.00293-09. Epub 2009 May 26. Antimicrob Agents Chemother. 2009. PMID: 19470509 Free PMC article.
-
Voriconazole in the management of nosocomial invasive fungal infections.Ther Clin Risk Manag. 2006 Jun;2(2):129-58. doi: 10.2147/tcrm.2006.2.2.129. Ther Clin Risk Manag. 2006. PMID: 18360588 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
